Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Senseonics
MedTech
Senseonics to link 365-day CGM to Sequel’s upcoming insulin pump
Designed for people with Type 1 diabetes, the companies said the launch of the combined system is slated for the third quarter of this year.
Conor Hale
Apr 29, 2025 11:30am
FDA clears Senseonics' 365-day Eversense CGM implant
Sep 17, 2024 11:00am
Ascensia completes European launch of Eversense 6-month CGM
Oct 10, 2022 10:22am
Senseonics' 180-day glucose sensor scores new European approval
Jun 16, 2022 11:55am
Ascensia Diabetes Care launches Eversense's 6-month CGM system
Apr 4, 2022 10:45am
Senseonics lands long-awaited FDA OK for 6-month CGM implant
Feb 11, 2022 9:42am
